|
|
Previous Article | Table of Contents | Next Article 
Blood, Vol. 92 No. 11 (December 1), 1998:
pp. 4167-4177
Role of Tissue Factor in Adhesion of Mononuclear Phagocytes to and
Trafficking Through Endothelium In Vitro
Gwendalyn J. Randolph,
Thomas Luther,
Sybille Albrecht,
Viktor Magdolen, and
William A. Muller
From the Department of Pathology, Cornell University Medical College,
New York, NY; the Institute of Pathology, Technical University of
Dresden, Dresden; and the Department of Gynecology, Technical
University of Munich, Munich, Germany.
An in vitro model consisting of endothelium grown on
collagen was used to investigate how mononuclear phagocytes traverse endothelium in the basal-to-apical direction (reverse transmigration), a process that mimics their migration across vascular and/or
lymphatic endothelium during atherosclerosis and resolution of
inflammation, respectively. Monoclonal antibody (MoAb) VIC7 against
tissue factor (TF) inhibited reverse transmigration by 77%.
Recombinant tissue factor fragments containing at least six amino acids
C-terminal to residue 202 also strongly inhibited reverse
transmigration. TF was absent on resting monocytes but was induced on
these cells after initial apical-to-basal transendothelial migration.
Two additional observations suggest that TF is involved in adhesion between mononuclear phagocytes and endothelium: (1) when monocytes were
incubated with lipopolysaccharide (LPS) to stimulate expression of TF
before they were added to endothelium, VIC7 or soluble TF modestly
inhibited their adhesion to the apical endothelial surface, each by
about 35%; and (2) endothelial cells specifically bound to surfaces
coated with TF fragments containing amino acids 202-219. This binding
was blocked by anti-TF MoAb, suggesting that endothelial cells bear a
receptor for TF. These data suggest that mononuclear phagocytes use TF, perhaps as an adhesive protein, to exit sites of
inflammation.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. Moosbauer, E. Morgenstern, S. L. Cuvelier, D. Manukyan, K. Bidzhekov, S. Albrecht, P. Lohse, K. D. Patel, and B. Engelmann
Eosinophils are a major intravascular location for tissue factor storage and exposure
Blood,
February 1, 2007;
109(3):
995 - 1002.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. E. Tilley, B. Pedersen, R. Pawlinski, Y. Sato, J. H. Erlich, Y. Shen, S. Day, Y. Huang, D. T. Eitzman, W. A. Boisvert, et al.
Atherosclerosis in Mice Is Not Affected by a Reduction in Tissue Factor Expression
Arterioscler. Thromb. Vasc. Biol.,
March 1, 2006;
26(3):
555 - 562.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Chen, M. Kasper, T. Heck, K. Nakagawa, P. M. Humpert, L. Bai, G. Wu, Y. Zhang, T. Luther, M. Andrassy, et al.
Tissue Factor as a Link Between Wounding and Tissue Repair
Diabetes,
July 1, 2005;
54(7):
2143 - 2154.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. V. M. Rao and U. R. Pendurthi
Tissue Factor-Factor VIIa Signaling
Arterioscler. Thromb. Vasc. Biol.,
January 1, 2005;
25(1):
47 - 56.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Qu, E. W. Edwards, F. Tacke, V. Angeli, J. Llodra, G. Sanchez-Schmitz, A. Garin, N. S. Haque, W. Peters, N. van Rooijen, et al.
Role of CCR8 and Other Chemokine Pathways in the Migration of Monocyte-derived Dendritic Cells to Lymph Nodes
J. Exp. Med.,
November 15, 2004;
200(10):
1231 - 1241.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Dorfleutner, E. Hintermann, T. Tarui, Y. Takada, and W. Ruf
Cross-talk of Integrin {alpha}3{beta}1 and Tissue Factor in Cell Migration
Mol. Biol. Cell,
October 1, 2004;
15(10):
4416 - 4425.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Sharma, E. Melis, M. J. Hickey, C. D. Clyne, J. Erlich, L. M. Khachigian, P. Davenport, E. Morand, P. Carmeliet, and P. G. Tipping
The Cytoplasmic Domain of Tissue Factor Contributes to Leukocyte Recruitment and Death in Endotoxemia
Am. J. Pathol.,
July 1, 2004;
165(1):
331 - 340.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Ahamed and W. Ruf
Protease-activated Receptor 2-dependent Phosphorylation of the Tissue Factor Cytoplasmic Domain
J. Biol. Chem.,
May 28, 2004;
279(22):
23038 - 23044.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Moldenhauer, M. Nociari, G. Lam, A. Salama, S. Rafii, and M. A.S. Moore
Tumor Necrosis Factor Alpha-Stimulated Endothelium: An Inducer of Dendritic Cell Development from Hematopoietic Progenitors and Myeloid Leukemic Cells
Stem Cells,
March 1, 2004;
22(2):
144 - 157.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. H. Yang, P. Hall, G. Milenkovski, L. Sharma, P. Hutchinson, E. Melis, P. Carmeliet, P. Tipping, and E. Morand
Reduction in Arthritis Severity and Modulation of Immune Function in Tissue Factor Cytoplasmic Domain Mutant Mice
Am. J. Pathol.,
January 1, 2004;
164(1):
109 - 117.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Crowe, T. Zhu, and W. A. Muller
The contribution of monocyte infection and trafficking to viral persistence, and maintenance of the viral reservoir in HIV infection
J. Leukoc. Biol.,
November 1, 2003;
74(5):
635 - 641.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Chong, T. H. Pohlman, C. R. Hampton, A. Shimamoto, N. Mackman, and E. D. Verrier
Tissue factor and thrombin mediate myocardial ischemia-reperfusion injury
Ann. Thorac. Surg.,
February 1, 2003;
75(2):
S649 - 655.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Qu, T. M. Moran, and G. J. Randolph
Autocrine Type I IFN and Contact with Endothelium Promote the Presentation of Influenza A Virus by Monocyte-Derived APC
J. Immunol.,
January 15, 2003;
170(2):
1010 - 1018.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. H. Versteeg, B. B. Sorensen, S. H. Slofstra, J. H. M. Van den Brande, J. C. Stam, P. M. P. van Bergen en Henegouwen, D. J. Richel, L. C. Petersen, and M. P. Peppelenbosch
VIIa/Tissue Factor Interaction Results in a Tissue Factor Cytoplasmic Domain-independent Activation of Protein Synthesis, p70, and p90 S6 Kinase Phosphorylation
J. Biol. Chem.,
July 19, 2002;
277(30):
27065 - 27072.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. P. Neve, D. Corseaux, G. Chinetti, C. Zawadzki, J.-C. Fruchart, P. Duriez, B. Staels, and B. Jude
PPAR{{alpha}} Agonists Inhibit Tissue Factor Expression in Human Monocytes and Macrophages
Circulation,
January 16, 2001;
103(2):
207 - 212.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. M. W. Verheul, A. S. Jorna, K. Hoekman, H. J. Broxterman, M. F. B. G. Gebbink, and H. M. Pinedo
Vascular endothelial growth factor-stimulated endothelial cells promote adhesion and activation of platelets
Blood,
December 15, 2000;
96(13):
4216 - 4221.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. H. Erlich, E. M. Boyle, J. Labriola, J. C. Kovacich, R. A. Santucci, C. Fearns, E. N. Morgan, W. Yun, T. Luther, O. Kojikawa, et al.
Inhibition of the Tissue Factor-Thrombin Pathway Limits Infarct Size after Myocardial Ischemia-Reperfusion Injury by Reducing Inflammation
Am. J. Pathol.,
December 1, 2000;
157(6):
1849 - 1862.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. N. Muller, E. M. A. Mervaala, F. Schmidt, J.-K. Park, R. Dechend, E. Genersch, V. Breu, B.-M. Loffler, D. Ganten, W. Schneider, et al.
Effect of Bosentan on NF-{kappa}B, Inflammation, and Tissue Factor in Angiotensin II-Induced End-Organ Damage
Hypertension,
August 1, 2000;
36(2):
282 - 290.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. N. Muller, E. M. A. Mervaala, R. Dechend, A. Fiebeler, J.-K. Park, F. Schmidt, J. Theuer, V. Breu, N. Mackman, T. Luther, et al.
Angiotensin II (AT1) Receptor Blockade Reduces Vascular Tissue Factor in Angiotensin II-Induced Cardiac Vasculopathy
Am. J. Pathol.,
July 1, 2000;
157(1):
111 - 122.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Rauch, D. Bonderman, B. Bohrmann, J. J. Badimon, J. Himber, M. A. Riederer, and Y. Nemerson
Transfer of tissue factor from leukocytes to platelets is mediated by CD15 and tissue factor
Blood,
July 1, 2000;
96(1):
170 - 175.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Dechend, V. Homuth, G. Wallukat, J. Kreuzer, J. K. Park, J. Theuer, A. Juepner, D. C. Gulba, N. Mackman, H. Haller, et al.
AT1 Receptor Agonistic Antibodies From Preeclamptic Patients Cause Vascular Cells to Express Tissue Factor
Circulation,
May 23, 2000;
101(20):
2382 - 2387.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. T. Esmon
Introduction: are natural anticoagulants candidates for modulating the inflammatory response to endotoxin?
Blood,
February 15, 2000;
95(4):
1113 - 1116.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Akuzawa, M. Kurabayashi, Y. Ohyama, M. Arai, and R. Nagai
Zinc Finger Transcription Factor Egr-1 Activates Flt-1 Gene Expression in THP-1 Cells on Induction for Macrophage Differentiation
Arterioscler. Thromb. Vasc. Biol.,
February 1, 2000;
20(2):
377 - 384.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Camerer, J.-A. Rottingen, E. Gjernes, K. Larsen, A. H. Skartlien, J.-G. Iversen, and H. Prydz
Coagulation Factors VIIa and Xa Induce Cell Signaling Leading to Up-regulation of the egr-1 Gene
J. Biol. Chem.,
November 5, 1999;
274(45):
32225 - 32233.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. H. Versteeg, I. Hoedemaeker, S. H. Diks, J. C. Stam, M. Spaargaren, P. M. P. van Bergen en Henegouwen, S. J. H. van Deventer, and M. P. Peppelenbosch
Factor VIIa/Tissue Factor-induced Signaling via Activation of Src-like Kinases, Phosphatidylinositol 3-Kinase, and Rac
J. Biol. Chem.,
September 8, 2000;
275(37):
28750 - 28756.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|